NCT04401878

Brief Summary

This study aims to investigate the ability of SPGB in the management of PDPH. Transcranial Doppler is also used as an measure to assess the block success by detecting the variability in the cerebral hemodynamics before and after the block.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2020

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 18, 2020

Completed
6 days until next milestone

Study Start

First participant enrolled

May 24, 2020

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 26, 2020

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 20, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 20, 2020

Completed
Last Updated

July 22, 2021

Status Verified

July 1, 2021

Enrollment Period

4 months

First QC Date

May 18, 2020

Last Update Submit

July 18, 2021

Conditions

Keywords

Accidental dural puncturePost dural puncture headacheSphenopalatine ganglion blockTranscranial Doppler

Outcome Measures

Primary Outcomes (1)

  • pain changes assessment by numeric rating scale (NRS)

    Pain score changes are assessed before and after the block using NRS in which zero is no pain and ten is worst pain imagined. pain was assessed throughout 24 hours after performing the block and Pain relief is considered when NRS ≤ 4.

    Before the block and at 30 minutes, 2 hours, 4 hours, 6 hours, 8 hours, 12 hours, and 24 hours after the block

Secondary Outcomes (1)

  • Detecting the changes in cerebral vessels caliber after doing SPGB

    TCD measurements are performed before SPGB is given to both groups, it is repeated again within an hour after the block for group (A) only.

Study Arms (2)

the treatment group (A)

EXPERIMENTAL

Patients who have PDPH are manged by SPGB, they are assessed by NRS before the block, at 30 mins, 2h, 4h, 6h, 12h, and 24hours after block. The patients are also examined by TCD before and after the block.

Drug: Sphenopalatine Ganglion Block using 2% lidocaine

control group (B)

EXPERIMENTAL

The control group (B) of 60 patients with no PDPH were examined by TCD

Drug: Sphenopalatine Ganglion Block using 2% lidocaine

Interventions

Sphenopalatine Ganglion Block is performed by a hollow culture swab that is connected with a 21-gauge syringe filled with three ml 2% lidocaine, inserted parallel to the floor of the nose until resistance is felt. The swab is at the posterior pharyngeal wall superior to the middle turbinate. The applicator was kept in the nostril for five to ten mins. The same procedure is done also in the second nostril. The patients are then examined by TCD.

Also known as: Transcranial Doppler (TCD) is also utilized
control group (B)the treatment group (A)

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • patients are considered who had an epidural anesthesia
  • Patients with ASA 1 and 2
  • Patients' age ranged from 18 to 60 years.

You may not qualify if:

  • Patients with septal perforation, nasal septum deviation,or nasal bleeding.
  • Patients have recent nasal trauma
  • Patients have recent nasal surgery
  • Patients have a nasal infection
  • Patients within ASA 3 and 4
  • Patients older than sixty yrs or younger than eighteen yrs.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Medicine, Zagazig University

Zagazig, 44519, Egypt

Location

Related Publications (2)

  • Basurto Ona X, Osorio D, Bonfill Cosp X. Drug therapy for treating post-dural puncture headache. Cochrane Database Syst Rev. 2015 Jul 15;2015(7):CD007887. doi: 10.1002/14651858.CD007887.pub3.

    PMID: 26176166BACKGROUND
  • Abdelhaleem NF, Othman HA, Abdel Razek GM, et al. (2019). Is the Combination of Glasgow Coma Scale and Transcranial Doppler Pulsatility Index Improving the Prediction of Outcome in Traumatic Brain Injury Patients? ZUMJ, 2019, 25(5): 529-538, doi:10.21608/zumj.2019.10082.10740

    RESULT

MeSH Terms

Conditions

Post-Dural Puncture Headache

Interventions

LidocaineUltrasonography, Doppler, Transcranial

Condition Hierarchy (Ancestors)

Headache Disorders, SecondaryHeadache DisordersBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Intervention Hierarchy (Ancestors)

AcetanilidesAnilidesAmidesOrganic ChemicalsAniline CompoundsAminesEchoencephalographyNeuroradiographyNeuroimagingDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisRadiographyUltrasonographyUltrasonography, DopplerDiagnostic Techniques, NeurologicalInvestigative Techniques

Study Officials

  • Naglaa Abdelhaleem, MD

    Faculty of Medicine, Zagazig University, Zagazig, Egypt.

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
DOUBLE
Who Masked
CARE PROVIDER, OUTCOMES ASSESSOR
Masking Details
Double (Care Providor, Outcome Assessor)
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This study is carried out in the Orthopedic unit and included 120 patients divided into two groups: the treatment group (A) and the control group (B). Group A recruit 60 patients with a past history of epidural anesthesia who suffered from of PDPH within five days after the dural puncture. Group B included 60 patients with a history of epidural anesthesia with no PDPH.
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer, Anesthesia and Surgical Intensive Care department, Faculty of Medicine

Study Record Dates

First Submitted

May 18, 2020

First Posted

May 26, 2020

Study Start

May 24, 2020

Primary Completion

September 20, 2020

Study Completion

September 20, 2020

Last Updated

July 22, 2021

Record last verified: 2021-07

Data Sharing

IPD Sharing
Will share

it will be available after completion of study and publication

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
The data will be available 3 months after publication of study
Access Criteria
By contacting the principal investigator
More information

Locations